This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
Many of your body's functions are affected by degenerative nerve diseases, including balance, movement, speech, breathing, and heart function. Many of these illnesses are inherited. A medical issue such as alcoholism, a tumor, or a stroke can sometimes be the cause. Toxins, chemicals, and viruses are some of the other possible reasons. It's not always clear what's causing the problem. Neurodegenerative disorders are defined by a progressive loss of brain function, resulting in a severe reduction in patient and family quality of life. The incidence of these diseases has increased throughout time as a result of rising life expectancy, and thus has been the subject of research. These diseases, which affect people of all ages, are one of the most serious medical and socioeconomic issues of our time. Improving people's quality of life is just as important as investing in disease prevention and treatment.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of